Jain P, Pawar RS, Pandey RS, Madan J, Pawar S, Lakshmi PK, et al. In-vitro in-vivo correlation (IVIVC) in nanomedicine: is protein corona the missing link? Biotechnol Adv. 2017;35:889–904.

Article  CAS  PubMed  Google Scholar 

Berrecoso G, Crecente-Campo J, Alonso MJ. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers. Drug Deliv Transl Res. 2020;10:730–50.

Article  CAS  PubMed  Google Scholar 

Papini E, Tavano R, Mancin F. Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines. Front Immunol. 2020;11:1–19.

Article  Google Scholar 

Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B: Biointerfaces. 2000;18:301–13.

Article  CAS  PubMed  Google Scholar 

Perry JL, Reuter KG, Kai MP, Herlihy KP, Jones SW, Luft JC, et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 2012;12:5304–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samadi N, van Steenbergen MJ, van den Dikkenberg JB, Vermonden T, van Nostrum CF, Amidi M, et al. Nanoparticles based on a hydrophilic polyester with a sheddable PEG coating for protein delivery. Pharm Res. 2014;31:2593–604.

Article  CAS  PubMed  Google Scholar 

Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25:1467–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francia V, Schiffelers RM, Cullis PR, Witzigmann D. The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug Chem. 2020;31:2046–59.

Article  CAS  PubMed  Google Scholar 

Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res. 2008;25:55–71.

Article  CAS  PubMed  Google Scholar 

Li SD, Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release. 2010;145:178–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci. 2021;118: e2109256118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dawson KA, Yan Y. Current understanding of biological identity at the nanoscale and future prospects. Nat Nanotechnol. Springer US; 2021;16:229–42.

Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci. 2007;104:2050–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molina-Crespo Á, Cadete A, Sarrio D, Gámez-Chiachio M, Martinez L, Chao K, et al. Intracellular delivery of an antibody targeting gasdermin-B reduces HER2 breast cancer aggressiveness. Clin Cancer Res. 2019;25:4846–58.

Article  CAS  PubMed  Google Scholar 

Abellan-Pose R, Teijeiro-Valiño C, Santander-Ortega MJ, Borrajo E, Vidal A, Garcia-Fuentes M, et al. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: effect of the particle size. Int J Pharm. 2016;509:107–17.

Article  CAS  PubMed  Google Scholar 

Ledo AM, Sasso MS, Bronte V, Marigo I, Boyd BJ, Garcia-Fuentes M, et al. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells. J Control Release. 2019;295:60–73.

Article  CAS  PubMed  Google Scholar 

Gonzalo T, Lollo G, Garcia-Fuentes M, Torres D, Correa J, Riguera R, et al. A new potential nano-oncological therapy based on polyamino acid nanocapsules. J Control Release. 2013;169:10–6.

Article  CAS  PubMed  Google Scholar 

Crecente-Campo J, Lorenzo-Abalde S, Mora A, Marzoa J, Csaba N, Blanco J, et al. Bilayer polymeric nanocapsules: a formulation approach for a thermostable and adjuvanted E. coli antigen vaccine. J Control Release. 2018;286:20–32.

Reimondez-Troitiño S, González-Aramundiz JV, Ruiz-Bañobre J, López-López R, Alonso MJ, Csaba N, et al. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells. Eur J Pharm Biopharm. 2019;142:449–59.

Article  PubMed  Google Scholar 

Lollo G, Rivera-Rodriguez GR, Bejaud J, Montier T, Passirani C, Benoit JP, et al. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel. Eur J Pharm Biopharm. 2014;87:47–54.

Article  CAS  PubMed  Google Scholar 

Crecente-Campo J, Alonso MJ. Engineering, on-demand manufacturing, and scaling-up of polymeric nanocapsules. Bioeng Transl Med. 2019;4:38–50.

Article  CAS  PubMed  Google Scholar 

Teijeiro-Valiño C, Novoa-Carballal R, Borrajo E, Vidal A, Alonso-Nocelo M, de la Fuente FM, et al. A multifunctional drug nanocarrier for efficient anticancer therapy. J Control Release. 2019;294:154–64.

Article  PubMed  Google Scholar 

González-Aramundiz JV, Presas E, Dalmau-Mena I, Martínez-Pulgarín S, Alonso C, Escribano JM, et al. Rational design of protamine nanocapsules as antigen delivery carriers. J Control Release. 2017;245:62–9.

Article  PubMed  Google Scholar 

Robla S, Prasanna M, Varela-Calviño R, Grandjean C, Csaba N. A chitosan-based nanosystem as pneumococcal vaccine delivery platform. Drug Deliv Transl Res. Springer US; 2021;11:581–97.

Borrajo E, Abellan-Pose R, Soto A, Garcia-Fuentes M, Csaba N, Alonso MJMJMJ, et al. Docetaxel-loaded polyglutamic acid-PEG nanocapsules for the treatment of metastatic cancer. J Control Release. Elsevier B.V.; 2016;238:263–71.

Fernández-Mariño I, Anfray C, Crecente-Campo J, Maeda A, Ummarino A, Teijeiro-Valiño C, et al. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages. Drug Deliv Transl Res. Springer US; 2022;Online ahead of print.

Lollo G, Hervella P, Calvo P, Avilés P, Guillen MJ, Garcia-Fuentes M, et al. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative. Int J Pharm. 2015;483:212–9.

Article  CAS  PubMed  Google Scholar 

Cordeiro AS, Crecente-Campo J, Bouzo BL, González SF, de la Fuente M, Alonso MJ. Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system. J Drug Target. 2019;27:646–58.

Article  CAS  PubMed  Google Scholar 

Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, et al. Nanotechnologies for the delivery of biologicals: historical perspective and current landscape. Adv Drug Deliv Rev. 2021;176.

Chetwynd AJ, Wheeler KE, Lynch I. Best practice in reporting corona studies: Minimum Information about Nanomaterial Biocorona Experiments (MINBE). Nano Today. Elsevier Ltd; 2019;28:100758.

Cadete A, Olivera A, Besev M, Dhal PK, Gonçalves L, Almeida AJ, et al. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs. Sci Rep. 2019;9:11565.

Article  PubMed  PubMed Central  Google Scholar 

Berrecoso G, Crecente-Campo J, Alonso MJ. Quantification of the actual composition of polymeric nanocapsules: a quality control analysis. Drug Deliv Transl Res. 2022;12:2865–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samaridou E, Kalamidas N, Santalices I, Crecente-Campo J, Alonso MJ. Tuning the PEG surface density of the PEG-PGA enveloped octaarginine-peptide nanocomplexes. Drug Deliv Transl Res. 2020;10:241–58.

Article  PubMed  Google Scholar 

Lee KL, Shukla S, Wu M, Ayat NR, El Sanadi CE, Wen AM, et al. Stealth filaments: polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X. Acta Biomater. 2015;19:166–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simonsen JB, Münter R. Pay attention to biological nanoparticles when studying the protein corona on nanomedicines. Angew Chemie - Int Ed. 2020;59:12584–8.

Article  CAS  Google Scholar 

Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543–52.

Article  CAS  PubMed  Google Scholar 

Thwala LN, Beloqui A, Csaba NS, González-Touceda D, Tovar S, Dieguez C, et al. The interaction of protamine nanocapsules with the intestinal epithelium: a mechanistic approach. J Control Release. 2016;243:109–20.

Article  CAS  PubMed  Google Scholar 

Dell’Orco D, Lundqvist M, Linse S, Cedervall T. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems. Nanomedicine. 2014;9:851–8.

Article  PubMed  Google Scholar 

Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, et al. The nanoparticle protein corona formed in human blood or human blood fractions. PLoS ONE. 2017;12: e0175871.

Article  PubMed  PubMed Central  Google Scholar 

Müller LK, Simon J, Rosenauer C, Mailänder V, Morsbach S, Landfester K. The transferability from animal models to humans: challenges regarding aggregation and protein corona formation of nanoparticles. Biomacromol. 2018;19:374–85.

Article  Google Scholar 

Müller J, Prozeller D, Ghazaryan A, Kokkinopoulou M, Mailänder V, Morsbach S, et al. Beyond the protein corona – lipids matter for biological response of nanocarriers. Acta Biomater. 2018;71:420–31.

Article  PubMed  Google Scholar 

Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, et al. Nanoparticle